439 related articles for article (PubMed ID: 20860466)
1. VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.
Suarez-Kurtz G; Amorim A; Damasceno A; Hutz MH; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Prata MJ; Ribeiro-dos-Santos A; Romano-Silva MA; Teixeira D; Struchiner CJ
Pharmacogenomics; 2010 Sep; 11(9):1257-67. PubMed ID: 20860466
[TBL] [Abstract][Full Text] [Related]
2. VKORC1 polymorphisms in Amerindian populations of Brazil.
Perini JA; Petzl-Erler ML; Tsuneto LT; Suarez-Kurtz G
Pharmacogenomics; 2008 Nov; 9(11):1623-9. PubMed ID: 19018718
[TBL] [Abstract][Full Text] [Related]
3. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
[TBL] [Abstract][Full Text] [Related]
4. CYP2C9 and VKORC1 polymorphisms are differently distributed in the Brazilian population according to self-declared ethnicity or genetic ancestry.
Soares RA; Santos PC; Machado-Coelho GL; do Nascimento RM; Mill JG; Krieger JE; Pereira AC
Genet Test Mol Biomarkers; 2012 Aug; 16(8):957-63. PubMed ID: 22808915
[TBL] [Abstract][Full Text] [Related]
5. Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.
Suarez-Kurtz G; Vargens DD; Santoro AB; Hutz MH; de Moraes ME; Pena SD; Ribeiro-dos-Santos Â; Romano-Silva MA; Struchiner CJ
PLoS One; 2014; 9(1):e83472. PubMed ID: 24427273
[TBL] [Abstract][Full Text] [Related]
6. VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.
Limdi NA; Beasley TM; Crowley MR; Goldstein JA; Rieder MJ; Flockhart DA; Arnett DK; Acton RT; Liu N
Pharmacogenomics; 2008 Oct; 9(10):1445-58. PubMed ID: 18855533
[TBL] [Abstract][Full Text] [Related]
7. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.
Limdi NA; Wadelius M; Cavallari L; Eriksson N; Crawford DC; Lee MT; Chen CH; Motsinger-Reif A; Sagreiya H; Liu N; Wu AH; Gage BF; Jorgensen A; Pirmohamed M; Shin JG; Suarez-Kurtz G; Kimmel SE; Johnson JA; Klein TE; Wagner MJ;
Blood; 2010 May; 115(18):3827-34. PubMed ID: 20203262
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients.
Perini JA; Struchiner CJ; Silva-Assunção E; Santana IS; Rangel F; Ojopi EB; Dias-Neto E; Suarez-Kurtz G
Clin Pharmacol Ther; 2008 Dec; 84(6):722-8. PubMed ID: 18754001
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic polymorphisms in Brazilian-born, first-generation Japanese descendants.
Perini JA; Vargens DD; Santana IS; Moriguchi EH; Ribeiro-Dos-Santos AK; Tsutsumi M; Suarez-Kurtz G
Braz J Med Biol Res; 2009 Dec; 42(12):1179-84. PubMed ID: 19882083
[TBL] [Abstract][Full Text] [Related]
10. VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.
Orsi FA; Annichino Bizzacchi JM; de Paula EV; Ozelo MC; Langley MR; Weck KE
Thromb Res; 2010 Sep; 126(3):e206-10. PubMed ID: 20615525
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.
Suarez-Kurtz G; Pena SD; Struchiner CJ; Hutz MH
Front Pharmacol; 2012; 3():191. PubMed ID: 23133420
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.
Shrif NE; Won HH; Lee ST; Park JH; Kim KK; Kim MJ; Kim S; Lee SY; Ki CS; Osman IM; Rhman EA; Ali IA; Idris MN; Kim JW
Eur J Clin Pharmacol; 2011 Nov; 67(11):1119-30. PubMed ID: 21590310
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic implications of population admixture: Brazil as a model case.
Suarez-Kurtz G; Paula DP; Struchiner CJ
Pharmacogenomics; 2014 Feb; 15(2):209-19. PubMed ID: 24444410
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of warfarin in populations of African descent.
Suarez-Kurtz G; Botton MR
Br J Clin Pharmacol; 2013 Feb; 75(2):334-46. PubMed ID: 22676711
[TBL] [Abstract][Full Text] [Related]
15. Distribution and linkage disequilibrium of the enhancer SNP rs5758550 among Latin American populations: influence of continental ancestry.
Elias ABR; Araújo GS; de Souza SJ; Suarez-Kurtz G
Pharmacogenet Genomics; 2020 Jun; 30(4):67-72. PubMed ID: 32187157
[TBL] [Abstract][Full Text] [Related]
16. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation.
Geisen C; Watzka M; Sittinger K; Steffens M; Daugela L; Seifried E; Müller CR; Wienker TF; Oldenburg J
Thromb Haemost; 2005 Oct; 94(4):773-9. PubMed ID: 16270629
[TBL] [Abstract][Full Text] [Related]
17. Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population.
Suarez-Kurtz G; Pena SD; Hutz MH
Pharmacogenomics; 2012 May; 13(7):771-7. PubMed ID: 22594509
[TBL] [Abstract][Full Text] [Related]
18. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
Scott SA; Jaremko M; Lubitz SA; Kornreich R; Halperin JL; Desnick RJ
Pharmacogenomics; 2009 Aug; 10(8):1243-55. PubMed ID: 19663669
[TBL] [Abstract][Full Text] [Related]
19. VKORC1 haplotypes in five East-Asian populations and Indians.
Lee MT; Chen CH; Chuang HP; Lu LS; Chou CH; Chen YT; Liu CY; Wen MS; Lu JJ; Chang CF; Wu JY; Chen YT
Pharmacogenomics; 2009 Oct; 10(10):1609-16. PubMed ID: 19842934
[TBL] [Abstract][Full Text] [Related]
20. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
Rieder MJ; Reiner AP; Gage BF; Nickerson DA; Eby CS; McLeod HL; Blough DK; Thummel KE; Veenstra DL; Rettie AE
N Engl J Med; 2005 Jun; 352(22):2285-93. PubMed ID: 15930419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
